Nuclear and nuclear envelope localization of dystrophin Dp71 and dystrophin‐associated proteins (DAPs) in the C2C12 muscle cells: DAPs nuclear localization is modulated during myogenesis

Dystrophin and dystrophin‐associated proteins (DAPs) form a complex around the sarcolemma, which gives stability to the sarcolemma and leads signal transduction. Recently, the nuclear presence of dystrophin Dp71 and DAPs has been revealed in different non‐muscle cell types, opening the possibility that these proteins could also be present in the nucleus of muscle cells. In this study, we analyzed by Immunofluorescence assays and Immunoblotting analysis of cell fractions the subcellular localization of Dp71 and DAPs in the C2C12 muscle cell line. We demonstrated the presence of Dp71, α‐sarcoglycan, α‐dystrobrevin, β‐dystroglycan and α‐syntrophin not only in plasma membrane but also in the nucleus of muscle cells. In addition, we found by Immunoprecipitation assays that these proteins form a nuclear complex. Interestingly, myogenesis modulates the presence and/or relative abundance of DAPs in the plasma membrane and nucleus as well as the composition of the nuclear complex. Finally, we demonstrated the presence of Dp71, α‐sarcoglycan, β‐dystroglycan, α‐dystrobrevin and α‐syntrophin in the C2C12 nuclear envelope fraction. Interestingly, α‐sarcoglycan and β‐dystroglycan proteins showed enrichment in the nuclear envelope, compared with the nuclear fraction, suggesting that they could function as inner nuclear membrane proteins underlying the secondary association of Dp71 and the remaining DAPs to the nuclear envelope. Nuclear envelope localization of Dp71 and DAPs might be involved in the nuclear envelope‐associated functions, such as nuclear structure and modulation of nuclear processes. J. Cell. Biochem. 105: 735–745, 2008. © 2008 Wiley‐Liss, Inc.

[1]  B. Cisneros,et al.  Differential expression and subcellular distribution of dystrophin Dp71 isoforms during differentiation process , 2003, Neuroscience.

[2]  N. Amariglio,et al.  Gene silencing at the nuclear periphery , 2007, The FEBS journal.

[3]  A. Monaco Dystrophin, the protein product of the Duchenne/Becker muscular dystrophy gene. , 1989, Trends in biochemical sciences.

[4]  G. Lyons,et al.  MyoD, myogenin independent differentiation of primordial myoblasts in mouse somites , 1992, The Journal of cell biology.

[5]  K. Davies,et al.  Characterisation of alpha-dystrobrevin in muscle. , 1998, Journal of cell science.

[6]  E. Friauf,et al.  A subcellular prefractionation protocol for minute amounts of mammalian cell cultures and tissue , 2005, Proteomics.

[7]  M. Matunis Isolation and fractionation of rat liver nuclear envelopes and nuclear pore complexes. , 2006, Methods.

[8]  Derek J. Blake,et al.  Different Dystrophin-like Complexes Are Expressed in Neurons and Glia , 1999, The Journal of cell biology.

[9]  H. Baumgarten,et al.  Nitric oxide synthase in skeletal muscle fibers: a signaling component of the dystrophin-glycoprotein complex. , 1999, Histology and histopathology.

[10]  J. Ervasti,et al.  Purification of dystrophin from skeletal muscle. , 1991, The Journal of biological chemistry.

[11]  M. Topham,et al.  Interaction of gamma 1-syntrophin with diacylglycerol kinase-zeta. Regulation of nuclear localization by PDZ interactions. , 2001, The Journal of biological chemistry.

[12]  K. Campbell,et al.  Expression of dystrophin-associated glycoproteins during human fetal muscle development: A preliminary immunocytochemical study , 1994, Neuromuscular Disorders.

[13]  H. Klamut,et al.  Dystrophin isoforms Dp71 and Dp427 have distinct roles in myogenic cells , 1999, Muscle & nerve.

[14]  H. Worman,et al.  How do mutations in lamins A and C cause disease? , 2004, The Journal of clinical investigation.

[15]  D. Bulman,et al.  Myogenic regulation of dystrophin gene expression. , 1989, British medical bulletin.

[16]  B. Chait,et al.  Proteomic analysis of the mammalian nuclear pore complex , 2002, The Journal of cell biology.

[17]  M. Shigekawa,et al.  Bidirectional Signaling between Sarcoglycans and the Integrin Adhesion System in Cultured L6 Myocytes* , 1998, The Journal of Biological Chemistry.

[18]  T. Bergman,et al.  Characterization of human alpha-dystrobrevin isoforms in HL-60 human promyelocytic leukemia cells undergoing granulocytic differentiation. , 2002, Molecular biology of the cell.

[19]  K. Wilson The nuclear envelope, muscular dystrophy and gene expression. , 2000, Trends in cell biology.

[20]  B. Cisneros,et al.  Characterization of a novel Dp71 dystrophin-associated protein complex (DAPC) present in the nucleus of HeLa cells: members of the nuclear DAPC associate with the nuclear matrix. , 2006, Experimental cell research.

[21]  U. Francke,et al.  Intragenic deletions in 21 Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD) families studied with the dystrophin cDNA: location of breakpoints on HindIII and BglII exon-containing fragment maps, meiotic and mitotic origin of the mutations. , 1988, American journal of human genetics.

[22]  S. Carbonetto,et al.  Dystroglycan contributes to the formation of multiple dystrophin‐like complexes in brain , 2001, Journal of neurochemistry.

[23]  R. Coral-Vázquez,et al.  Partial characterization of the mouse α-sarcoglycan promoter and its responsiveness to MyoD , 2006 .

[24]  G. Macchia,et al.  Association of the Dystroglycan Complex Isolated from Bovine Brain Synaptosomes with Proteins Involved in Signal Transduction , 1999, Journal of neurochemistry.

[25]  K. Davies,et al.  Assembly of multiple dystrobrevin-containing complexes in the kidney. , 2000, Journal of cell science.

[26]  J. Sahel,et al.  Characterization of the intermolecular associations of the dystrophin-associated glycoprotein complex in retinal Müller glial cells. , 2000, Journal of cell science.

[27]  O. Ibraghimov-Beskrovnaya,et al.  Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix , 1992, Nature.

[28]  J. Towbin,et al.  Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. , 2000, The Journal of clinical investigation.

[29]  Eric P. Hoffman,et al.  Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.

[30]  S. Carbonetto,et al.  α-Dystroglycan Is a Laminin Receptor Involved in Extracellular Matrix Assembly on Myotubes and Muscle Cell Viability , 1999, The Journal of cell biology.

[31]  L. Kunkel,et al.  The Three Human Syntrophin Genes Are Expressed in Diverse Tissues, Have Distinct Chromosomal Locations, and Each Bind to Dystrophin and Its Relatives (*) , 1996, The Journal of Biological Chemistry.

[32]  K. Davies,et al.  beta-dystrobrevin, a member of the dystrophin-related protein family. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  F. Rivier,et al.  Dystrophin and Utrophin Complexed with Different Associated Proteins in Cardiac Purkinje Fibres , 1999, The Histochemical Journal.

[34]  A. Levey,et al.  Cell-specific Sorting of Biogenic Amine Transporters Expressed in Epithelial Cells* , 1996, The Journal of Biological Chemistry.

[35]  Mutations in the human δ-sarcoglycan gene in familial and sporadic dilated cardiomyopathy , 2000 .

[36]  K. Campbell,et al.  Sarcospan, the 25-kDa Transmembrane Component of the Dystrophin-Glycoprotein Complex* , 1997, The Journal of Biological Chemistry.

[37]  Y. Sunada,et al.  Characterization of the Transmembrane Molecular Architecture of the Dystroglycan Complex in Schwann Cells* , 1999, The Journal of Biological Chemistry.

[38]  M. Topham,et al.  Interaction of γ1-Syntrophin with Diacylglycerol Kinase-ζ , 2001, The Journal of Biological Chemistry.

[39]  U. Nudel,et al.  Specificity of expression of the muscle and brain dystrophin gene promoters in muscle and brain cells , 1990, Neuron.

[40]  R. Foisner,et al.  Nuclear envelope and nuclear matrix: interactions and dynamics , 2001, Cellular and Molecular Life Sciences CMLS.

[41]  M. Lisanti,et al.  Expression of Caveolin-3 in Skeletal, Cardiac, and Smooth Muscle Cells , 1996, The Journal of Biological Chemistry.

[42]  V. Sartorelli,et al.  Mechanisms underlying the transcriptional regulation of skeletal myogenesis. , 2005, Current opinion in genetics & development.

[43]  K. Davies,et al.  The dystrophin-associated protein complex. , 2002, Journal of cell science.

[44]  S. Noguchi,et al.  Identification of myogenesis-dependent transcriptional enhancers in promoter region of mouse gamma-sarcoglycan gene. , 2001, European journal of biochemistry.

[45]  P. Gómez,et al.  Dystrophin Dp71 Expression Is Down-regulated during Myogenesis , 2005, Journal of Biological Chemistry.